| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Biocardia, Inc. (BCDA) has 9 insiders with recent SEC Form 4 filings, including 14 buys and 0 sells. BCDA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 280.8K | $315.9K | +6.0K | |
| VP | 47.0K | $52.9K | - | |
| CFO | 46.3K | $52.1K | - | |
| Dir | 15.7K | $17.7K | - | |
| Dir | 15.6K | $17.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | Altman Peter48 | President And CEO | Buy | 5,000 | $1.11 | $5,550.00 | +1.8% | - | - | |
| Apr 21, 2026 | Altman Peter48 | President And CEO | Buy | 1,000 | $1.23 | $1,230.00 | +0.2% | - | - | |
| Mar 25, 2026 | Altman Peter48 | President And CEO | Buy | 900 | $1.23 | $1,110.00 | +0.2% | - | - | |
| Jan 21, 2026 | Altman Peter48 | President And CEO | Buy | 900 | $1.33 | $1,194.00 | +0.2% | - | - | |
| Dec 17, 2025 | Altman Peter48 | President And CEO | Buy | 1,100 | $1.31 | $1,444.00 | +0.2% | +0.8% | - | |
| Sep 19, 2025 | Blank Andrew Scott47 | Director | Buy | 288,000 | $1.25 | $360,000.00 | +83.2% | +10.3% | - | |
| Sep 19, 2025 | Altman Peter48 | President And CEO | Buy | 48,000 | $1.25 | $60,000.00 | +28.4% | +10.3% | - | |
| Sep 19, 2025 | Stertzer Simon H | Director | Buy | 398,400 | $1.25 | $498,000.00 | +206.8% | +10.3% | - | |
| Aug 22, 2025 | Altman Peter48 | President And CEO | Buy | 700 | $1.83 | $1,281.00 | +0.4% | -33.0% | - | |
| Aug 13, 2025 | Altman Peter48 | President And CEO | Buy | 100 | $1.83 | $183.00 | - | -28.5% | - |